V36L (p.Val36Leu) variant of NCSTN (Nicastrin)
V36L (p.Val36Leu) in NCSTN (Nicastrin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes structural context.
V36L (p.Val36Leu) variant details
- p.Val36Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.327
- REVEL 0.37
- ESM-1b 0.00
- AlphaMissense 0.73
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available